VTI.AX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 jun 2024 @ 05:19):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific...

Stats
Dagens volum	11 439
Gjennomsnittsvolum	38 175
Markedsverdi	7.07M
EPS	$-0.0325 ( Q4 \| 2023-12-31 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.900 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

AHX.AX -2.90%

ALC.AX 6.25%

ANN.AX -2.41%

AT1.AX 0.00%

AVR.AX 0.00%

CAJ.AX -4.76%

CAU.AX 0.00%

CDX.AX -7.14%

CGS.AX -0.89%

COH.AX -2.89%

CYC.AX -6.51%

EBO.AX -1.81%

EHE.AX 0.33%

EMD.AX 12.20%

EMV.AX -11.11%

FPH.AX -1.26%

HLA.AX 0.17%

HLS.AX -4.33%

HMD.AX 13.04%

IBX.AX -1.18%

IDX.AX -3.00%

IHL.AX -10.87%

IMR.AX -0.94%

IPD.AX -1.39%

M7T.AX -0.78%

MDR.AX -5.00%

MVF.AX -3.11%

MX1.AX -3.61%

NAN.AX -4.01%

NTI.AX 1.43%

NXS.AX -6.38%

ONE.AX -3.75%

PCK.AX 3.70%

PME.AX -5.31%

PNV.AX -4.90%

PSQ.AX -0.79%

REG.AX -3.21%

RHC.AX -1.60%

RHY.AX -3.23%

RSH.AX 13.04%

SHL.AX -2.43%

SIG.AX -2.35%

SNZ.AX 0.81%

TTB.AX 0.00%

UBI.AX 0.00%

VHT.AX 0.44%

VTI.AX 0.00%

Korrelasjon (AI algo v.1.1b): Undervalued: 0.07% $0.135 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Visioneering Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Visioneering Økonomi

Annual	2023
Omsetning:	$13.06M
Bruttogevinst:	$7.17M (54.90 %)
EPS:	$-0.150

FY	2023
Omsetning:	$13.06M
Bruttogevinst:	$7.17M (54.90 %)
EPS:	$-0.150

FY	2022
Omsetning:	$7.29M
Bruttogevinst:	$3.32M (45.52 %)
EPS:	$-0.220

FY	2021
Omsetning:	$7.15M
Bruttogevinst:	$2.97M (41.47 %)
EPS:	$-0.313

Financial Reports:

No articles found.

Visioneering Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Visioneering

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. The company's flagship product comprises NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. Visioneering Technologies, Inc. was incorporated in 2008 and is headquartered in Alpharetta, Georgia.